61 assets in Morbid Obesity

Therapeutic assets addressing Morbid Obesity, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ketorolac Morbid Obesity	Hospital dos Lusíadas	N/A	D (30)
Losartan Morbid Obesity	Norwegian University of Science and Technology	N/A	D (30)
Mazdutide Morbid Obesity	Beijing Friendship Hospital	N/A	D (30)
Milk Polar Lipid-Rich Dairy Powder Morbid Obesity	Hospices Civils de Lyon	N/A	D (30)
Oxalidine Morbid Obesity	Yongtao Sun	P4	NR ()

Showing 51 to 61 of 61 assets

PreviousPage 2 of 2Next